Log in

NASDAQ:DOVA - Dova Pharmaceuticals Stock Price, Forecast & News

$28.04
0.00 (0.00 %)
(As of 11/12/2019)
Add
Compare
Today's Range
$28.04
Now: $28.04▼
$28.04
50-Day Range
$28.04
MA: $28.04▼
$28.04
52-Week Range
$5.62
Now: $28.04▼
$28.54
Volume35,036 shs
Average Volume499,313 shs
Market Capitalization$807.55 million
P/E RatioN/A
Dividend YieldN/A
Beta2.74
Dova Pharmaceuticals, Inc, a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. The company's lead product candidate is DOPTELET that is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure. It also develops DOPTELET for the treatment of chronic immune thrombocytopenia and chemotherapy-induced thrombocytopenia. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DOVA
Previous Symbol
CUSIPN/A
CIK1685071
Webhttp://www.dova.com/
Phone919-748-5975

Debt

Debt-to-Equity Ratio0.41
Current Ratio5.64
Quick Ratio5.37

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$10.35 million
Price / Sales78.02
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.71 per share
Price / Book10.35

Profitability

EPS (Most Recent Fiscal Year)($2.60)
Net Income$-72,280,000.00
Net Margins-544.09%
Return on Equity-101.60%
Return on Assets-67.21%

Miscellaneous

Employees115
Outstanding Shares28,800,000
Market Cap$807.55 million
Next Earnings DateN/A
OptionableOptionable

Receive DOVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:DOVA Rates by TradingView

Stock Trades Or Predictions (Ad)


Want to know which stocks should be on your radar this week? Every Sunday we send out the 3 Stock Trades that we predict will be big winners for the week ahead.

Dova Pharmaceuticals (NASDAQ:DOVA) Frequently Asked Questions

What is Dova Pharmaceuticals' stock symbol?

Dova Pharmaceuticals trades on the NASDAQ under the ticker symbol "DOVA."

How were Dova Pharmaceuticals' earnings last quarter?

Dova Pharmaceuticals Inc (NASDAQ:DOVA) posted its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.60) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.57) by $0.03. The firm had revenue of $3.52 million for the quarter, compared to analysts' expectations of $5.63 million. Dova Pharmaceuticals had a negative net margin of 544.09% and a negative return on equity of 101.60%. View Dova Pharmaceuticals' Earnings History.

What price target have analysts set for DOVA?

6 equities research analysts have issued 12 month price targets for Dova Pharmaceuticals' stock. Their forecasts range from $15.00 to $30.00. On average, they anticipate Dova Pharmaceuticals' share price to reach $26.42 in the next year. This suggests that the stock has a possible downside of 5.8%. View Analyst Price Targets for Dova Pharmaceuticals.

What is the consensus analysts' recommendation for Dova Pharmaceuticals?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dova Pharmaceuticals in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Dova Pharmaceuticals.

Has Dova Pharmaceuticals been receiving favorable news coverage?

News articles about DOVA stock have trended negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Dova Pharmaceuticals earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Dova Pharmaceuticals.

Who are some of Dova Pharmaceuticals' key competitors?

What other stocks do shareholders of Dova Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dova Pharmaceuticals investors own include Global Blood Therapeutics (GBT), Arrowhead Pharmaceuticals (ARWR), Sasol (SSL), Aldeyra Therapeutics (ALDX), TESARO (TSRO), TherapeuticsMD (TXMD), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Heron Therapeutics (HRTX) and Immunomedics (IMMU).

Who are Dova Pharmaceuticals' key executives?

Dova Pharmaceuticals' management team includes the folowing people:
  • Dr. David S. Zaccardelli, Pres & CEO (Age 54)
  • Mr. Mark W. Hahn, CFO & Sec. (Age 56)
  • Mr. Kevin Laliberte, Sr. VP of Product Devel. (Age 41)
  • Mr. Jason Levine, VP of Marketing
  • Mr. Ilija Zlatar, Head of U.S. Sales

When did Dova Pharmaceuticals IPO?

(DOVA) raised $66 million in an initial public offering on Thursday, June 29th 2017. The company issued 4,100,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and Leerink Partners acted as the underwriters for the IPO.

How do I buy shares of Dova Pharmaceuticals?

Shares of DOVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Dova Pharmaceuticals' stock price today?

One share of DOVA stock can currently be purchased for approximately $28.04.

How big of a company is Dova Pharmaceuticals?

Dova Pharmaceuticals has a market capitalization of $807.55 million and generates $10.35 million in revenue each year. The company earns $-72,280,000.00 in net income (profit) each year or ($2.60) on an earnings per share basis. Dova Pharmaceuticals employs 115 workers across the globe.View Additional Information About Dova Pharmaceuticals.

What is Dova Pharmaceuticals' official website?

The official website for Dova Pharmaceuticals is http://www.dova.com/.

How can I contact Dova Pharmaceuticals?

Dova Pharmaceuticals' mailing address is 240 Leigh Farm Road Suite 245, Durham NC, 27707. The company can be reached via phone at 919-748-5975 or via email at [email protected]


MarketBeat Community Rating for Dova Pharmaceuticals (NASDAQ DOVA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  213 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  427
MarketBeat's community ratings are surveys of what our community members think about Dova Pharmaceuticals and other stocks. Vote "Outperform" if you believe DOVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: Pattern Day Trader
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel